LEITE, A. L. M.; http://lattes.cnpq.br/9958048542567378; LEITE, Ana Luiza Marinho.
Resumo:
Irritable Bowel Syndrome is a functional disorder of the gastrointestinal tract, belonging to
the class of inflammatory bowel diseases, which in the last 10 years have caused
approximately 50,000 hospital admissions in Brazil alone, 75% of them with
urgency character. Currently, non-pharmacological measures have been used in its
treatment, among these measures the modification of the patient's diet with the incorporation of
nutraceuticals has the potential to be a safe and effective option. Thus, there is a demand
world for the generation of new approaches and efficient technologies for the correct use
of nutraceuticals in the treatment of inflammatory bowel diseases. The present work had
with the objective to carry out a technological prospection about the use of nutraceuticals in the
Irritable Bowel Syndrome therapy. For the prospection, the keywords were used.
key nutraceutic*, irritable*, bowel* and syndrome*. The search for deposited patents was
carried out in the Patent Inspiration database, in the months of April and May 2021. The results
demonstrate records of 66 patent documents, most of them registered in Switzerland, country
headquarters of the food giant Nestlé. The study demonstrates the current scenario of work with
focus on the development and propagation of new approaches to the use of
nutraceuticals.
